ISO 14001 can be beneficial for a company and also can be significant. The ISO 14000 set of standards provides practical apparatus for companies and organizations of all kinds seeking to manage their environmental jobs. ISO 14001:2015 and its associating standards, like the ISO 14006:2011 focus on the environmental systems to attain this. The other standards in the family focus on specific approaches such as audits, communications, cataloging and life cycle analysis, as well as environmental challenges such as climate change.
ISO 14001 is the international standard that specifies necessities for an effective environmental management system (EMS). It provides a framework that an organization can follow, rather than be establishing environmental performance requirements. Part of the ISO 14000 families of standards on environmental management, ISO 14001 is a voluntary standard that organizations can certify to.
Integrating it with other management systems standards, most commonly ISO 9001 can further help in accomplishing organizational objectives. The International Organization for Standardization or ISO describes an environmental management system as a part of the management scheme which is used to administer environmental factors and thus fulfills compliance obligations, and address threats and opportunities. The framework in the ISO 14001 standard can be used within a plan-do-check-act or the PDCA approach to constant development. Every Organization wants to reduce costs at anyway, this is a fact of life in today’s economy, but one may wonder how an environmental management system can help with this cost control phenomena.
The major factor is that this can happen is by using the system itself to identify, control, monitor and reduce the number of environmental incidents that may occur, which can cost your company through liability costs of fines, cleanup, and reparations. Secondly, the organization can use the improvement aspect of the environmental management
Latest posts by Maria Burns (see all)
- Magna Announces Fourth Quarter and 2017 Results and Raises Quarterly Cash Dividend by 20% - February 22, 2018
- Leading Token Venture Investor, Multicoin Capital Partners With Apex Token Fund for Upcoming ICO - February 22, 2018
- Novo Nordisk successfully completes the first phase 3a trial, PIONEER 1, with oral semaglutide - February 22, 2018